🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

The early rhythm control group was randomized to single lead ECG monitoring twice weekly and w/ symptoms. Do you think this monitoring strategy was important to their benefit? Are you using these digital health devices in this way in your patients? #CardsJC

~30% of patients were asymptomatic at time of enrollment and the effect of rhythm control seemed to be consistent across EHRA symptom score. Do you see us doing more trials of early rhythm control specifically in asymptomatic patients? #CardsJC

Pts were enrolled <12 mo after an AF diagnosis. We don’t know much about how the diagnosis was made... considering ~30% of patients were asymptomatic at enrollment should we actively look for asymptomatic patients with AF to treat with *even earlier* rhythm control? #CardsJC

Is it surprising that at the end of the study there was no difference in number of patients experiencing symptoms between early rhythm control and usual care? #CardsJC

After quantifying LVH, EchoNet-LVH predicts etiology (#Amyloidosis, HCM vs. other etiologies of LVH), providing an end-to-end pipeline for disease screening. This was validated both at Stanford Department of Medicine and Cedars-Sinai Ronald Witteles Jignesh Patel euan ashley Florian Rader

1) In person meetings are personal, meaningful, and here to stay 2) Lots of great science got done during a pandemic 3) Universal 👍 and high demand for #HRX !!! See you Dec 2-4 in San Diego!

As my program director Ronald Witteles used to say: "Fluid restriction does only one thing for your patients with heart failure: make them thirsty." So pls pass the pitcher & ditch the salt. Julia Caton #MedTwitter #TWDFNR #JHM #CardioTwitter journalofhospitalmedicine.com/jhospmed/artic…

After 2 yrs, I'm releasing IntroECG today: first ever soup-to-nuts ML library for ECGs is here! github.com/pelias1525/Int… Many thx AMIA American College of Cardiology euan ashley Stanford AIMI David Ouyang, MD Columbia Cardiology Fellows Adler Perotte Matthew Lungren MD MPH Eric Topol @AnnMarieNavar Eric D. Peterson

🤔Approach to a young man with complete heart block⁉️ 🔥Next level teaching in this case by StanfordCVFellowship Pablo Sanchez, MD James Tooley, MD Maggie Ning & Expert Ronald Witteles 👏🏽 🔗cardionerds.com/157-case-repor… 🎨InfoGraphic by University of Chicago Cardiology Fellowship Shirlene Obuobi MD Ian Hackett, MD Mark Belkin

Extremely grateful for all my colleagues and mentors at StanfordCVFellowship StanfordMedRes over the past 7 years, but excited to start a new chapter at UCSF Cardiology for EP!

We are excited to share the results from this year's Digital Health Consumer Adoption Survey in collaboration with Rock Health. Check out the link below for a deep dive on #telemedicine and see what the data says about #DigitalHealth trends in 2021: rockhealth.com/insights/consu…

Can’t believe it’s over. What an amazing privilege and responsibility to learn alongside such fun, smart, and supportive cofellows! I owe so much to so many. I’ll miss you next year. #graduation StanfordCVFellowship StanfordMedRes @aaelezaby Pablo Sanchez, MD Chad Weldy, MD, PhD Maggie Ning

Excited to hang out with old and new friends and talk at my alma mater! UC San Francisco James Tooley, MD James Pirruccello Geoff Tison RimaArnaout Neal Yuan, MD John Chorba UCSF Echo UCSF Cardiology

In SVT EP study, SA-VA differences delivered from RV basal septum (distal His) allow for 1) a more robust differentiation of AVNRT and AVRT than those from RV apex and 2) a rapid identification of 4 general AP sites. Mel Scheinman, MD Edward Gerstenfeld Henry Hsia contentalerts.jacc.org/ct/61722281:6G…

Great to get out of the lab and experience the beauty of Marin with UCSF Heart & Vascular Care EP fellows. All great hikers too! Chris Wong Rachita Navara, MD FACC FHRS James Tooley, MD Stacey Howell Babikir Kheiri

The FDA has approved teplizumab, the first drug with the ability to change the course of type 1 diabetes, or any autoimmune disease. Yale School of Medicine played a crucial role in the drug’s trials. Yale School of Medicine #Yale medicine.yale.edu/news-article/f…